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The current coronavirus disease 2019 (COVID-19) crisis 
has emerged as a global pandemic.1,2 Iran has been widely 
exposed to the COVID-19 and has the fifth highest death 
toll from COVID-19. The Taleghani Liver Transplant 
Center, one of the high-volume liver transplant centers in 
the Middle East, has provided new guidelines for its ward 
and attempted to provide an appropriate model for these 
patients based on previous pandemic studies. According 
to the published studies, the first experience with a 
pandemic in the transplantation era was due to H5N1 
pandemic.3 In addition, the information on the influenza 
virus reminds us that transplanted patients are likely to 
constitute a larger number of symptomatic patients due to 
immunosuppression, if they are exposed to the pathogen 
and the disease.
An Italian study showed that 20% of healthcare workers 
were infected with the new coronavirus and some of 
them died.4 Therefore, in order to minimize the risk of 
healthcare providers’ exposure and reducing patients’ flow 
to hospitals, telemedicine could be used as a cheap and 
effective method for educating patients in developing 
countries.5 Patients should be trained about the risks 
of attending public centers and disease prevention, 
considering the high burden of liver transplantation 
and its heavy costs to health systems. Therefore, specific 
training should be provided on the Internet and web-
based platforms for these patients. They should inform 
their transplant physicians before any referral to the 
health centers for a preliminary evaluation of symptoms 
and provide a complete list of their medications and their 
transplant records.
Previously, it has been demonstrated that higher virus 
levels could be found in the transplanted tissue after death 
when compared to the non-transplanted individuals.6 
Moreover, in a study by Al-Ghamdi et al, unfavorable 
outcomes were more frequently reported for transplanted 
individuals in the MERS-CoV virus.7 Therefore, the 
Taleghani Center decided to focus on pandemic prevention 
of post-transplant infection and limit its surgical operations 
to emergency surgery considering the low probable 
outcome. Furthermore, owing to the pandemic nature of 
this disease and the need for ICU beds, it is recommended 
to avoid over-hospitalization and elective surgery, to 
consider isolated places for the patients’ follow-up in the 
early days, and to conduct patients’ follow-up and referrals 
through phone calls or clinically outside the hospital.
Another aspect highly considered in liver transplant 
patients is the mental health status of these patients 
associated with the poorer transplantation outcome 
and inappropriate drug consumption by the patients. 
Regarding COVID 19, Xiang showed that like other 
pandemics, there is a growing concern about the death 
of patients and quarantined people.8 A study by Bao 
also reported stress was caused by uncertainty about the 
condition and the exact time of disease control.9 Thus, they 
predicted a higher risk of hopelessness and anxiety owing 
to chronic disease in transplanted patients. Undoubtedly, 
these patients should undergo psychiatric telephone 
counseling during the crisis for psychological assessments 
and stress reduction techniques, home exercise activities, 
and proper nutrition. Moreover, Wang et al showed that 
lower family income was associated with a lower rate of 
health-related quality of life.10 Accordingly, during this 
pandemic, financial support for these patients from the 
government or other foundations presumably improve 
their quality of life. 




 Arch Iran Med, Volume 23, Issue 7, July 2020                                                        508
Dooghaie Moghadam et al 
with a dramatic loss of quality of life.11 Therefore, this group 
of patients need greater attention during this pandemic. 
Transplant candidates encounter a significant range of 
stressors before their transplantation12; thus, they should 
also be reassured about receiving their transplants after the 
disease is controlled and the crisis is resolved. According 
to Banihashemi et al, a healthy lifestyle, financial support 
and treatment of major psychiatric disorders improve the 
quality of life in Iranian liver transplant patients.13 Hence, 
it is recommended to provide psychiatric services first to 
patients with lower MELD scores and to those who have 
already undergone transplantation due to the limited 
financial resources in the health system. Overall, it can 
be concluded that offering special support is necessary 
for transplant candidates. The patients’ access to their 
medication is another problem in developing countries 
during this pandemic. It is recommended to supply these 
medications to the nearest local health center during the 
crisis and deliver them to the patients after approval by the 
Transplant Center.
It should be noted that transplant patients likely infected 
with the new coronavirus are treated with common 
relevant protocols; hence, appropriate measures should 
be taken into consideration regarding training physicians 
about the possible drug interactions with transplant 
patients’ medications.
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